Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
110 participants
INTERVENTIONAL
2026-02-15
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Experiences on Acute Pain and Distress
NCT03599479
Patient Receptiveness to Using Virtual Reality
NCT03528668
Virtual Reality (VR) Regulators
NCT06184529
Healthy Volunteer Undergoing Painful Stimuli With and Without Hypnosis and Virtual Reality
NCT04107558
Virtual Reality in the Management of Painful or Anxiety-provoking Procedures in Emergency Departments
NCT06425835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fear-inducing Virtual Reality (VR) experience
Participants will complete a single virtual reality (VR) exposure lasting approximately 1-2 minutes, involving a fear-inducing scenario (e.g., walking a plank above a high-rise building or canyon).
Fear-inducing Virtual Reality (VR) experience
Participants will complete a single virtual reality (VR) exposure involving a fear-inducing scenario (e.g., walking a plank above a high-rise building or canyon).
Neutral Virtual Reality (VR) experience
Participants will complete a single virtual reality (VR) exposure lasting approximately 1-2 minutes, involving a neutral scenario (e.g., walking to the edge of a curb at street level).
Neutral Virtual Reality (VR) experience
Participants will complete a single virtual reality (VR) exposure involving a fear-inducing scenario (e.g., walking to the edge of a curb at street level).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fear-inducing Virtual Reality (VR) experience
Participants will complete a single virtual reality (VR) exposure involving a fear-inducing scenario (e.g., walking a plank above a high-rise building or canyon).
Neutral Virtual Reality (VR) experience
Participants will complete a single virtual reality (VR) exposure involving a fear-inducing scenario (e.g., walking to the edge of a curb at street level).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking
* Normal or corrected vision.
* Able to provide consent.
Exclusion Criteria
* VR contraindications: epilepsy, migraines, flu, sleep deprivation, etc.
* More than minimal VR experience assessed via self-report (e.g., How often have you used virtual reality in the past? 0=never, 6=very frequently)
* Extreme phobia of heights and/or spiders will be assessed using Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) specific phobia subscale.
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Britton
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer Britton, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami
Coral Gables, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20241195
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.